EL EssilorLuxottica Société anonyme
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About EssilorLuxottica (EPA: EL)
›
EssilorLuxottica (EPA: EL) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 213,909 employees.
The shares were at 174.90 EUR on 20 November 2026, down 42.2% over 52 weeks. Its 52-week range is 138.35 EUR to 317.00 EUR: the price is 44.8% below the high and 26.4% above the low.
At a market capitalisation of 81.04B EUR, it trades at 33.0 times trailing earnings and 22.4 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 51.8, a discount of 36% for EL. It pays a dividend yielding 2.24% (it pays out 75% of its earnings), against a median of 0.71% among the dividend payers in that peer group.
EssilorLuxottica reports return on equity of 6.0%, an operating margin of 12.8% and revenue up 5.7% year over year.
Its debt exceeds its cash by 13.38B EUR, a debt-to-equity ratio of 0.37. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 23 analysts cover the stock, with an average rating of Buy; their mean price target of 216.57 EUR is 23.8% above the current price. The next earnings report is expected on 11 February 2027.